Patents by Inventor Fengfeng YAN

Fengfeng YAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260200834
    Abstract: Provided in the present invention is a method for preparing an oseltamivir intermediate. The method comprises the following steps: subjecting compound 1 to a tert-butyl removal reaction under an acidic condition to obtain compound 2, wherein the acidic condition is trichloroacetic acid, chloroacetic acid, dichloroacetic acid, acetic acid, methanesulfonic acid, benzenesulfonic acid, formic acid or a mixture thereof. The post-treatment step comprises: after the reaction is completed, dissolving the compound 2 with an organic solvent to obtain a solution containing a compound of formula 2, then cooling the solution containing the compound of formula 2 obtained above, adjusting the pH value with an aqueous solution of an inorganic base, performing extraction and layering, and concentrating same to obtain the title compound.
    Type: Application
    Filed: December 14, 2023
    Publication date: July 16, 2026
    Applicant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
    Inventors: Wanchun WANG, Xinlei CHEN, Zunjun LIANG, Fengfeng YAN
  • Publication number: 20260132100
    Abstract: The present invention relates to a method for purifying pregabalin, comprising the following steps: 1) heating a reaction solution, maintaining the temperature and removing impurities; and 2) adding an acid into the reaction solution in step 1) to adjust the pH value, crystallizing and centrifugally drying the solution to obtain high-purity pregabalin. The pregabalin prepared and obtained by employing the purification method of the present invention has a product purity that reaches 99.8% or above, a product yield of 90% or above, an impurity X and impurity Y content that is ?0.05%, and has no detected impurity peak the relative retention time of which is 1.3.
    Type: Application
    Filed: March 7, 2022
    Publication date: May 14, 2026
    Inventors: Yougui WANG, Changqing CAI, Jun TAN, Yuanxun ZHU, Fengfeng YAN
  • Publication number: 20250214933
    Abstract: The present invention relates to the field of pharmaceutical chemical engineering, in particular to a method for purifying a levetiracetam intermediate, which comprises the following steps: (1) hydrolyzing and acidifying a crude product of a compound of formula III and performing crystallization to obtain a compound of formula IV; and (2) subjecting the compound of formula IV to an esterification reaction and separation to obtain a purified compound of formula III. The present method has a purification effect obviously superior to that of a physical purification mode, can reach a total yield of 90% or above, and has a great practical value.
    Type: Application
    Filed: March 23, 2022
    Publication date: July 3, 2025
    Inventors: Fengfeng YAN, Hui CHEN, Yulong GONG, Yuanxun ZHU
  • Publication number: 20250115584
    Abstract: The present invention belongs to the field of pharmaceutical and chemical engineering, and relates to a high-purity losartan potassium and a preparation method therefor. The present invention also relates to a high-purity losartan or a pharmaceutically acceptable salt thereof and a preparation method therefor. The present invention uses organic phosphorus to reduce an azide compound to an amino compound so that the genotoxicity of losartan or a pharmaceutically acceptable salt thereof can be well controlled. The method of the present invention involves fewer steps, uses a small amount of reagent, does not require activated carbon decolorization, and produces a high-purity product, and therefore is suitable for industrial production and is very practical.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 10, 2025
    Inventors: Shengjun Li, Yang Zheng, Aixing Li, Cuiting Liang, Mingyong Bai, Zhantao Zhang, Zunjun Liang, Fengfeng Yan
  • Patent number: 12227476
    Abstract: A high-quality (RS)-?-ethyl-2-oxo-1-pyrrolidine acetic acid acquired by racemization recovery is provided. A method provided significantly increases the quality and appearance of the product (RS)-?-ethyl-2-oxo-1-pyrrolidine acetic acid recovered using racemization and does not affect the product yield.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: February 18, 2025
    Assignee: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
    Inventors: Bingxin Liu, Yulong Gong, Yuanxun Zhu, Fengfeng Yan
  • Publication number: 20250051311
    Abstract: Disclosed in the present invention is a method for preparing high-purity losartan, which belongs to the fields of medicine and chemical engineering. The losartan is obtained by means of a multi-stage temperature reaction in the presence of a catalyst and sodium azide, wherein the temperature in the first stage of the multi-stage temperature reaction is higher than that in the second stage. According to the method, the generation of dimer impurities can be reduced, and the risk of impurities being introduced into a finished losartan potassium product is reduced.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 13, 2025
    Inventors: Xian Yang, Yang Zheng, Aixing Li, Jing Liu, Zunjun Liang, Fengfeng Yan
  • Publication number: 20220162165
    Abstract: A high-quality (RS)-?-ethyl-2-oxo-1-pyrrolidine acetic acid acquired by racemization recovery is provided. A method provided significantly increases the quality and appearance of the product (RS)-?-ethyl-2-oxo-1-pyrrolidine acetic acid recovered using racemization and does not affect the product yield.
    Type: Application
    Filed: April 17, 2020
    Publication date: May 26, 2022
    Inventors: Bingxin LIU, Yulong GONG, Yuanxun ZHU, Fengfeng YAN